OpenAlex
PricingAboutJobs
Log inGet started
Work

Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

HTML PDF

Year: 2003
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
DOI: 10.1093/annonc/mdg346
Authors: P. Reichardt, G. von Minckwitz, P.C. Thuss-Patience, W. Jonat, H. Kölbl, F. Jänicke, D.G. Kieback, W. Kuhn, A.E. Schindler, S. Mohrmann, M. Kaufmann, H.J. Lück
Institutions: Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, University Hospital Frankfurt, University Hospital Schleswig-Holstein, Martin Luther University Halle-Wittenberg, Maastricht University Medical Centre, University Medical Center Freiburg, Technical University of Munich, Essen University Hospital, Heinrich Heine University Düsseldorf, Medizinische Hochschule Hannover
Language: English

Topic: Cancer Treatment and Pharmacology
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: capecitabine, metastatic breast cancer, taxane-refractory disease, paclitaxel, docetaxel, fluoropyrimidine, oral chemotherapy, hand-foot syndrome, treatment-related adverse events, tumor control rate, second-line therapy
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2143399650
FWCI: 8.166
Cites: 18
Cited by: 247
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms